Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARILYN JACKSON

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1811097744
CMS profile
500512
Location
NEW YORK, NY

General Payments · PY2018–2024

$527.11

  • Reported across 23 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$260.27

10 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $260.27 10

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $232.13 8
Alnylam Pharmaceuticals Inc. $28.14 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $34.17 2
PY2019 $18.17 1
PY2020 $38.69 2
PY2021 $37.50 1
PY2022 $45.88 2
PY2023 $92.43 5
PY2024 $260.27 10

Payment records · PY2024 (10)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alnylam Pharmaceuticals Inc. $13.72 01/29/2024 Food and Beverage Undisputed 01/23/2026 1125848400 CMS
Alnylam Pharmaceuticals Inc. $14.42 01/29/2024 Food and Beverage Undisputed 01/23/2026 1125848402 CMS
GlaxoSmithKline, LLC. $18.50 01/08/2024 Food and Beverage Undisputed 01/23/2026 1115992529 CMS
GlaxoSmithKline, LLC. $16.42 06/03/2024 Food and Beverage Undisputed 01/23/2026 1116451981 CMS
GlaxoSmithKline, LLC. $22.15 07/22/2024 Food and Beverage Undisputed 01/23/2026 1116428562 CMS
GlaxoSmithKline, LLC. $16.21 08/26/2024 Food and Beverage Undisputed 01/23/2026 1116274849 CMS
GlaxoSmithKline, LLC. $118.73 09/10/2024 Food and Beverage Undisputed 01/23/2026 1116444668 CMS
GlaxoSmithKline, LLC. $12.69 09/16/2024 Food and Beverage Undisputed 01/23/2026 1116362765 CMS
GlaxoSmithKline, LLC. $15.78 10/28/2024 Food and Beverage Undisputed 01/23/2026 1116701389 CMS
GlaxoSmithKline, LLC. $11.65 12/16/2024 Food and Beverage Undisputed 01/23/2026 1116660075 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.